[EFFECT] Lyra Therapeutics, Inc. SEC Filing

(Neutral)

(Neutral)

Form Type

EFFECT

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Accepted by SEC EDGAR 03/27/2026 - 12:15 AM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 26, 2026

Accession Number:

0001193125-26-124481

Submission Type:

POS AM

Source: View Original Filing on SEC EDGAR